quinacrine and 4-hydroxy-2-nonenal

quinacrine has been researched along with 4-hydroxy-2-nonenal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Halliwell, B; Lu, XR; Ong, WY	1

Other Studies

1 other study(ies) available for quinacrine and 4-hydroxy-2-nonenal

Article	Year
The phospholipase A2 inhibitor quinacrine prevents increased immunoreactivity to cytoplasmic phospholipase A2 (cPLA2) and hydroxynonenal (HNE) in neurons of the lateral septum following fimbria-fornix transection. Experimental brain research, 2001, Volume: 138, Issue:4 Topics: Acetylcholine; Aldehydes; Animals; Choline O-Acetyltransferase; Cytoplasm; Enzyme Inhibitors; Fornix, Brain; Glutamic Acid; Immunohistochemistry; Lipid Peroxidation; Male; Microscopy, Electron; Nerve Degeneration; Neurons; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Rats, Wistar; Septal Nuclei; Time Factors; Up-Regulation	2001

Article

Year

The phospholipase A2 inhibitor quinacrine prevents increased immunoreactivity to cytoplasmic phospholipase A2 (cPLA2) and hydroxynonenal (HNE) in neurons of the lateral septum following fimbria-fornix transection.

Experimental brain research, 2001, Volume: 138, Issue:4

Topics: Acetylcholine; Aldehydes; Animals; Choline O-Acetyltransferase; Cytoplasm; Enzyme Inhibitors; Fornix, Brain; Glutamic Acid; Immunohistochemistry; Lipid Peroxidation; Male; Microscopy, Electron; Nerve Degeneration; Neurons; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Rats, Wistar; Septal Nuclei; Time Factors; Up-Regulation

2001